Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2012
11/27/2012US8318696 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative
11/27/2012US8318689 SiRNA-based cancer treatment
11/27/2012US8318480 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
11/27/2012US8318425 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/27/2012US8318421 Hepatitis-C virus testing
11/27/2012US8318179 Neisserial vaccines
11/27/2012US8318177 Viral chemokine-antigen fusion proteins
11/27/2012US8318173 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
11/27/2012CA2680292C Intermediates useful for the preparation of n-substituted carbamoyloxyalkyl-azolium derivatives
11/27/2012CA2629570C Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
11/27/2012CA2598521C Heterocyclylamide-substituted imidazoles
11/27/2012CA2577745C Hcv inhibiting bi-cyclic pyrimidines
11/27/2012CA2531766C Entry inhibitors of the hiv virus
11/27/2012CA2487805C Peptide deformylase inhibitors
11/27/2012CA2481390C Nanoparticulate megestrol formulations
11/27/2012CA2452836C Meningococcus adhesins nada, app and orf 40
11/27/2012CA2451051C Siglec inhibitors
11/27/2012CA2449830C New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
11/27/2012CA2449157C Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
11/27/2012CA2432525C Streptococcus pyogenes antigens and corresponding dna fragments
11/27/2012CA2422057C Dipeptidyl peptidase i crystal structure and its uses
11/27/2012CA2347131C Modified peptides as therapeutic agents
11/27/2012CA2181832C Immunization by inoculation of dna transcription unit
11/25/2012CA2777024A1 Sprayable gel wound dressing
11/22/2012WO2012158811A2 Purine monophosphate prodrugs for treatment of viral infections
11/22/2012WO2012158789A2 Methods and compositions for inhibiting neddylation of proteins
11/22/2012WO2012158529A2 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/22/2012WO2012158271A1 Bridged polycyclic compounds as antiviral agents
11/22/2012WO2012158216A1 Methods of treating a disorder associated with sequestered bacteria
11/22/2012WO2012158048A1 A dietary supplement
11/22/2012WO2012158002A1 Medicinal preparation "renessans" having an antibacterial, anti-ulcerous and immuno-modulating action
11/22/2012WO2012157751A1 Diagnosis of respiratory tract infectious diseases using urine specimens
11/22/2012WO2012157750A1 Diagnosis of respiratory tract infectious disease using blood specimens
11/22/2012WO2012157479A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
11/22/2012WO2012157408A1 Cytotoxic t cell inducer
11/22/2012WO2012156825A1 Peptide-based hiv pre-integration complex inhibitors
11/22/2012WO2012156750A1 Hiv vaccine
11/22/2012WO2012156533A1 New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
11/22/2012WO2012156498A1 Quinazoline derivatives for the treatment of viral infections and further diseases
11/22/2012WO2012156391A1 Vaccine against streptococcus pneumoniae
11/22/2012WO2012155981A1 New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
11/22/2012WO2012155819A1 Hbv specific antibody
11/22/2012WO2012155751A1 A method for preparing hbv vaccine comprising aluminum adjuvant
11/22/2012WO2012155328A1 Composition comprising endostatin and rnai molecules and the use thereof
11/22/2012WO2012155262A1 Virus-like particles and process for preparing same
11/22/2012WO2012155261A1 Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response
11/22/2012WO2012155226A1 Method for producing pyrostegia venusta derivatives, pyrostegia venusta derivatives, pharmaceutical compositions and uses thereof
11/22/2012WO2012155203A1 Regulation of nitric oxide release and biofilm development
11/22/2012WO2012155172A1 Method of treatment or prophylaxis of bacterial vaginosis
11/22/2012WO2012135112A3 Methods for preparing deuterated 1,2,3-triazoles
11/22/2012WO2012131714A4 Veterinary herbal compositions and medicaments thereof
11/22/2012WO2012126178A3 Pharmaceutical composition for treating hepatic disease
11/22/2012WO2012122533A3 Compositions and methods related to antibodies to staphylococcal proteins isda or isdb
11/22/2012WO2012090124A3 IN SITU GENERATION OF PEROXYCARBOXYLIC ACIDS AT ALKALINE pH, AND METHODS OF USE THEREOF
11/22/2012WO2012080918A3 Wear resistant antimicrobial compositions and methods of use
11/22/2012US20120297495 Zinc-finger nuclease and rna interference mediated inactivation of viral genomes
11/22/2012US20120296072 N-terminally chemically modified protein compositions and methods
11/22/2012US20120295988 Pharmaceutical Compositions of Dispersions of Amorphous Drugs Mixed with Polymers
11/22/2012US20120295977 Organosulfur prodrugs for the prevention and treatment of infectious diseases
11/22/2012US20120295968 Pharmaceutical Composition Comprising Cannabinoids
11/22/2012US20120295959 Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
11/22/2012US20120295954 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
11/22/2012US20120295939 Anti-viral agent
11/22/2012US20120295930 Novel process for the preparation of cis-nucleoside derivative
11/22/2012US20120295920 5-amino-4-hydroxypentoyl amides
11/22/2012US20120295912 Piperazinylpiperidine derivatives as chemokine receptor antagonists
11/22/2012US20120295909 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application
11/22/2012US20120295903 Flavin derivatives
11/22/2012US20120295902 Hetaryl-[1,8]naphthyridine derivatives
11/22/2012US20120295898 Antiviral Therapy
11/22/2012US20120295886 Antiviral compounds and their methods of use
11/22/2012US20120295884 Complement pathway modulators and uses thereof
11/22/2012US20120295877 Therapeutic Compounds
11/22/2012US20120295843 Combination therapy for the treatment of hcv infection
11/22/2012US20120295842 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
11/22/2012US20120295841 Sanglifehrin Based Compounds
11/22/2012US20120295840 Treatment of aspergillus infections with alpha thymosin peptides
11/22/2012US20120295839 Method of treatment and prophylaxis of bacterial vaginosis
11/22/2012US20120295837 Novel antimicrobial agents
11/22/2012US20120294953 Surface Modified Biological Materials
11/22/2012US20120294948 Vaccine
11/22/2012US20120294946 Modulator
11/22/2012US20120294940 Rapidly disintegrating tablet in oral cavity
11/22/2012US20120294935 Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
11/22/2012US20120294934 Transdermal compositions for anticholinergic agents
11/22/2012US20120294933 Use of PVP-Iodine Liposomes for Treatment of Acne
11/22/2012US20120294926 Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
11/22/2012US20120294924 Peptide-Lipid Conjugates And Uses Thereof
11/22/2012US20120294920 Wound dressing
11/22/2012US20120294901 Novel cochleate formulations
11/22/2012US20120294900 Phosphorylated and Branched Dihydroxy-Pentane-Dione (DPD) Analogs as Quorum Sensing Inhibitors in Bacteria
11/22/2012US20120294899 Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
11/22/2012US20120294892 Avirulent Salmonella Gallinarum Variants and Pharmaceutical Composition Using the Same
11/22/2012US20120294891 Materials and methods for detecting, preventing, and treating retroviral infection
11/22/2012US20120294890 Recombinant Parainfluenza Virus Expression Systems And Vaccines
11/22/2012US20120294889 Chimeric Flavivirus Vaccines
11/22/2012US20120294885 Toll-like receptor-7 and -8 modulatory 1h imidazoquinoline derived compounds
11/22/2012US20120294882 Modified tuberculosis antigens
11/22/2012US20120294881 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
11/22/2012US20120294880 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
1 ... 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 ... 1798